Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

ClinicalTrials.gov ID: NCT00036114

Public ClinicalTrials.gov record NCT00036114. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00036114
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • aripiprazole Drug

Drug

Eligibility (public fields only)

Age range
55 Years to 95 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2000
Primary completion
Jul 31, 2003
Completion
Jul 31, 2003
Last update posted
Nov 10, 2013

2000 – 2003

United States locations

U.S. sites
41
U.S. states
22
U.S. cities
41
Facility City State ZIP Site status
Local Institution Tuscaloosa Alabama
Local Institution Scottsdale Arizona
Local Institution Cerritos California
Local Institution Granada Hills California
Local Institution Los Angeles California
Local Institution San Diego California
Local Institution Torrance California
Local Institution Denver Colorado
Local Institution Hamden Connecticut
Local Institution Miami Florida
Local Institution North Miami Beach Florida
Local Institution West Palm Beach Florida
Local Institution Atlanta Georgia
Local Institution Augusta Georgia
Local Institution Macon Georgia
Local Institution Honolulu Hawaii
Local Institution North Chicago Illinois
Local Institution Springfield Illinois
Local Institution New Orleans Louisiana
Local Institution Shreveport Louisiana
Local Institution Baltimore Maryland
Local Institution Newton Center Massachusetts
Local Institution Springfield Massachusetts
Local Institution Wellesley Hills Massachusetts
Local Institution Lyons New Jersey
Local Institution Albany New York
Local Institution Lawrence New York
Local Institution Montrose New York
Local Institution Northport New York
Local Institution White Plains New York
Local Institution Raleigh North Carolina
Local Institution Beachwood Ohio
Local Institution Portland Oregon
Local Institution Hershey Pennsylvania
Local Institution Austin Texas
Local Institution Dallas Texas
Local Institution San Antonio Texas
Local Institution Wichita Falls Texas
Local Institution Bennington Vermont
Local Institution Charlottesville Virginia
Local Institution Seattle Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00036114, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 10, 2013 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00036114 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →